Related Experiment Video

Updated: Mar 17, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K

Role of microRNA in prostate cancer stem/progenitor cells regulation

Z-Q Tao1, A-M Shi, R Li

  • 1Department of Science and Education, Xuzhou Central Hospital, Xuzhou. taoziqi@163.com.

European Review for Medical and Pharmacological Sciences
|July 28, 2016
PubMed

Insights

Cancer stem cells drive tumor growth and treatment resistance. This review explores microRNA regulation in prostate cancer stem cells for targeted therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Stem Cell Research

Background:

  • Human tumors harbor cancer stem cells (CSCs) responsible for tumor initiation, metastasis, and therapeutic resistance.
  • Understanding CSC-specific regulatory mechanisms is vital for developing targeted therapies.
  • MicroRNAs (miRNAs) have emerged as key regulators in various biological processes, including cancer.

Purpose of the Study:

  • To review the significant advancements in understanding microRNA regulation within prostate cancer stem cells.
  • To highlight the role of miRNAs in prostate carcinogenesis and CSC maintenance.
  • To provide insights into potential miRNA-based therapeutic strategies for prostate cancer.

Main Methods:

  • Literature review of recent studies on miRNA and prostate cancer stem cells.
  • Analysis of key regulatory pathways involving miRNAs in prostate carcinogenesis.
  • Synthesis of current knowledge on miRNA-mediated control of CSC properties.

Main Results:

  • CSCs are critical drivers of prostate cancer progression and treatment failure.
  • Specific miRNAs play crucial roles in regulating CSC self-renewal, differentiation, and survival.
  • Dysregulation of miRNAs contributes to the development and maintenance of the CSC phenotype in prostate cancer.

Conclusions:

  • MicroRNA dysregulation is a key factor in prostate cancer stem cell biology.
  • Targeting specific miRNAs offers a promising strategy for developing novel prostate cancer therapeutics.
  • Further research into miRNA-CSC interactions is essential for advancing prostate cancer treatment.

More Related Videos

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

25.1K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.3K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K